ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 844

Toll-Like Receptor 9-Independent and Immune Complex-Independent Interferon-α Production by Neutrophils Upon Netosis in Response to Circulating Chromatin

Dennis Lindau1, Julie Mussard2, Armin Rabsteyn1, Matthieu Ribon2, Ina Kötter3, Annette Igney3, Gosse Adema4, Marie-Christophe Boissier5, Hans-Georg Rammensee1 and Patrice Decker6, 1Department of Immunology, University of Tübingen, Institute for Cell Biology, Tübingen, Germany, 2INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité and Rheumatology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France, 3Department of Internal Medicine II, Rheumatology Division, Tübingen, Germany, 4Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Nijmegen, Netherlands, 5Avicenne Hospital, Rheumatology Department, Bobigny, France, 6EA4222, Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: interferons, neutrophils, nucleosomes and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Chromatin (which is composed of DNA and histones) represents a major autoantigen in systemic lupus erythematosus (SLE). Interferon-α (IFN-α) plays an important role in lupus development. Although activated plasmacytoid dendritic cells (pDC) are believed to be the main producers of IFN-α in SLE, pDC represent a minor cell population. On the other hand, neutrophils represent 50 % of total blood leukocytes and are activated in SLE, especially by chromatin. Moreover, neutrophils form immunogenic neutrophil extracellular traps (NET) in SLE. Toll-like receptor (TLR) 9 recognizes certain forms of DNA but its role in SLE is still not elucidated. We therefore sought to determine the cellular source of IFN-α as well as the natural stimuli in SLE, the mechanism and the impact of TLR9.

Methods: Chromatin (mono-nucleosomes) was purified from calf thymus. PBMC and neutrophils were isolated from healthy individuals and SLE patients. Mouse neutrophils were purified from the bone marrow. Cells were activated with different stimuli and IFN-α production/secretion was estimated by flow cytometry, ELISA and a bioassay. Gene expression was analyzed by qRT-PCR. Neutrophil activation was verified by flow cytometry and ELISA. NET induction was estimated by confocal microscopy.

Results: Isolated neutrophils produce IFN-α upon stimulation with chromatin. IFN-α secretion by neutrophils was observed with steady-state neutrophils, and not pro-inflammatory neutrophils, from both healthy donors and SLE patients whereas pDC were less efficient. Neutrophil-derived IFN-α was detected in response to free chromatin, and not chromatin-containing immune complexes, as well as TLR9 agonists. Nucleosome-induced IFN-α production by neutrophils was associated with IL-8 secretion, CD66b up-regulation, ROS production and NET formation (NETosis). Neutrophil priming is not required. In low-responders, autologous PBMC sustain IFN-α secretion by chromatin-activated neutrophils in co-cultures. In contrast to TLR9 agonists, chromatin-induced IFN-α secretion occurs independently of TLR9 since neutrophils isolated from both wild-type and TLR9-deficient mice were activated. Finally, chromatin increases gene expression levels of IFN-α and several DNA sensors, e.g. AIM2 and STING.

Conclusion: Neutrophils represent also an important source of IFN-α. IFN-α was detected at the mRNA and protein levels and in an active and secreted form. This is the first report showing both that steady-state neutrophils can secrete IFN-α and identifying a natural lupus stimulus involved. Since both normal and lupus neutrophils have the capability of producing IFN-α, a key event is thus the presence of increased concentrations of circulating nucleosomes in SLE patients. Chromatin-activated neutrophils (in addition to pDC and low-density granulocytes) may secrete IFN-α early during the lupus disease, before immune complexes are produced. The generation of NET and the expression of genes involved in the recognition of DNA may strengthen pDC activation and DNA-mediated activation.


Disclosure:

D. Lindau,
None;

J. Mussard,
None;

A. Rabsteyn,
None;

M. Ribon,
None;

I. Kötter,
None;

A. Igney,
None;

G. Adema,
None;

M. C. Boissier,
None;

H. G. Rammensee,
None;

P. Decker,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/toll-like-receptor-9-independent-and-immune-complex-independent-interferon-%ce%b1-production-by-neutrophils-upon-netosis-in-response-to-circulating-chromatin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology